A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.

Recruiting now

Conditions studied: PTCL

In brief

The efficacy and safety of chidamide in first-line maintenance therapy for PTCL will be assessed through a retrospective case analysis.

Key facts

Study ID

NCT05967949

Run by

The First Affiliated Hospital with Nanjing Medical University

People needed

200

Starts

2023-04-01

Expected to finish

2028-04-01

Last updated by the study team

2023-08-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• (1) Age: 18 years and older; (2) Gender: Male/Female; (3) Diagnosed with PTCL; (4) Received chidamide as maintenance therapy after first-line treatment.

You may not qualify if…

• (1) Patients with other types of lymphomas; (2) Pregnant women.

Where it is running

• Hematological Department, People's Hospital of Jiangsu Province — Nanjing, Jiangsu, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.